The patient was diagnosed with acute myeloid leukaemia AML-M2, t (8, 21) (q22; q11), -Y, AML1/ETO (+), c-Kit D816Y mutation, indicating a high risk of disease relapse (15, 16). This evidence concerns the gene KIT and acute myeloid leukemia.